delta(2-89)-tissue plasminogen activator

-delta-2-Pyrroline,1-benzoyl-5-methyl- (2CI)

-delta-2-1,3,4-Thiadiazolin-5-one,2-(dimethylamino)- (8CI)

-delta-2-Cyclohexenone,5-ethyl-3-methoxy-5-methyl-

-delta-2-1,2,4-Thiadiazoline--delta-5,N-carbamic acid,4-methyl-,ethyl ester (5CI)

-delta-2(1H),-alpha--Quinoxalineacetonitrile (8CI)

-delta-2-5-Isoxazolinecarbinol,-alpha-,-alpha--diethyl-3,4-diphenyl-,N-oxide (2CI)

4-((Cyclohexylamino)methyl)benzoic acid hydrochloride

1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine

2-Methoxy-6-(pyrazol-1-yl)-benzonitrile

1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-

(4-Methyl-tetrahydro-furan-2-yl)-methanol

N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide

4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde

tert-Butyl-DL-alanine

4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide

N-[3-(Aminooxy)propyl]-N-butyl-1-butanamine